TrianglePUBLICATIONS · 32702309
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2020 Aug
- First author
- Weiss AR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Weiss AR
- type
- Author
- name
- Chen YL
- type
- Author
- name
- Scharschmidt TJ
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Tian J
- type
- Author
- name
- Black JO
- type
- Author
- name
- Davis JL
- type
- Author
- name
- Fanburg-Smith JC
- type
- Author
- name
- Zambrano E
- type
- Author
- name
- Anderson J
- type
- Author
- name
- Arens R
- type
- Author
- name
- Binitie O
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Weiss AR
- type
- Author
- name
- Chen YL
- type
- Author
- name
- Scharschmidt TJ
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Tian J
- type
- Author
- name
- Black JO
- type
- Author
- name
- Davis JL
- type
- Author
- name
- Fanburg-Smith JC
- type
- Author
- name
- Zambrano E
- type
- Author
- name
- Anderson J
- type
- Author
- name
- Arens R
- type
- Author
- name
- Binitie O
- type
- Author
- bibliography ids
- nci-bib-d29bd1e2a95c9e68b9908f4b
- book metadata
- content sha256
- 2fdac21cdf9e2d832ec15849c742b2ed356b0eb32ff1eab02f9686ba5652ea21
- document type
- citation
- dois
- 10.1016/S1470-2045(20)30325-9
- electronic publication date
- display
- 2020 Jul 20
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32702309
- immutable id
- pubmed:32702309@2fdac21cdf9e2d832ec15849c742b2ed356b0eb32ff1eab02f9686ba5652ea21
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 8
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1110-1122
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32702309
- provenance
- batch id
- 40d9eae1f1d369f13109
- provider
- NCBI PubMed ESummary
- record sha256
- d530d12a40e9b8b508964a927197653078dd92700b0fb29230293ce6b40647a3
- response sha256
- 03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
- retrieved at
- 2026-09-09T23:47:52.637547+00:00
- publication date
- display
- 2020 Aug
- precision
- month
- year
- 2020
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Preserved source evidence · Not medical advice